- The European Patent Office issues a Notice of Allowance to SteadyMed (NASDAQ:STDY +3.1%) related to claims of infusion-site pain reduction via the delivery of a topical anaesthetic through the underside of its PatchPump infusion system for drugs administered subcutaneously.
- The company's patent application was No. 13720085.3.